Literature DB >> 28754777

Quantitative liver MRI including extracellular volume fraction for non-invasive quantification of liver fibrosis: a prospective proof-of-concept study.

Julian A Luetkens1, Sabine Klein2, Jonel Trebicka2,3,4,5, Guido M Kukuk1, Frank Traeber1, Frederic C Schmeel1, Alois M Sprinkart1, Daniel L R Kuetting1, Wolfgang Block1, Kanishka Hittatiya6, Frank E Uschner2, Robert Schierwagen2, Juergen Gieseke1,7, Hans H Schild1.   

Abstract

Entities:  

Keywords:  abdominal MRI; chronic liver disease; hepatic fibrosis

Mesh：

Year:  2017        PMID： 28754777     DOI： 10.1136/gutjnl-2017-314561

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

Review 1.  Clinical application and technical considerations of T1 & T2(*) mapping in cardiac, liver, and renal imaging.

Authors:  Ilona A Dekkers; Hildo J Lamb
Journal:  Br J Radiol       Date:  2018-07-23       Impact factor: 3.039

2.  Assessment of liver cirrhosis severity with extracellular volume fraction MRI.

Authors:  Narine Mesropyan; Patrick A Kupczyk; Leona Dold; Michael Praktiknjo; Johannes Chang; Alexander Isaak; Christoph Endler; Dmitrij Kravchenko; Leon M Bischoff; Alois M Sprinkart; Claus C Pieper; Daniel Kuetting; Christian Jansen; Ulrike I Attenberger; Julian A Luetkens
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

Review 3.  Managing portal hypertension in patients with liver cirrhosis.

Authors:  Tilman Sauerbruch; Robert Schierwagen; Jonel Trebicka
Journal:  F1000Res       Date:  2018-05-02

4.  Quantification of liver fibrosis: extracellular volume fraction using an MRI bolus-only technique in a rat animal model.

Authors:  Julian A Luetkens; Sabine Klein; Frank Träber; Wolfgang Block; Frederic C Schmeel; Alois M Sprinkart; Daniel L R Kuetting; Frank E Uschner; Robert Schierwagen; Daniel Thomas; Jonel Trebicka; Guido M Kukuk
Journal:  Eur Radiol Exp       Date:  2019-05-29

5.  Diagnostic value of magnetic resonance parametric mapping for non-invasive assessment of liver fibrosis in patients with primary sclerosing cholangitis.

Authors:  Narine Mesropyan; Patrick Kupczyk; Guido M Kukuk; Leona Dold; Tobias Weismueller; Christoph Endler; Alexander Isaak; Anton Faron; Alois M Sprinkart; Claus C Pieper; Daniel Kuetting; Christian P Strassburg; Ulrike I Attenberger; Julian A Luetkens
Journal:  BMC Med Imaging       Date:  2021-04-07       Impact factor: 1.930

6.  Efficacy Analysis of Double-Low Dynamic Contrast-Enhanced CT and Hepatic Extracellular Volume Fraction in the Diagnosis of Liver Fibrosis.

Authors:  Zhandong Liang; Yanxia Liu; Yuanwen Nie
Journal:  Contrast Media Mol Imaging       Date:  2022-08-17       Impact factor: 3.009

Review 7.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

Review 8.  Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy.

Authors:  Yasuko Iwakiri; Jonel Trebicka
Journal:  JHEP Rep       Date:  2021-06-04

9.  Synthetic extracellular volume fraction without hematocrit sampling for hepatic applications.

Authors:  Narine Mesropyan; Patrick Kupczyk; Alexander Isaak; Christoph Endler; Anton Faron; Leona Dold; Alois M Sprinkart; Claus C Pieper; Daniel Kuetting; Ulrike Attenberger; Julian A Luetkens
Journal:  Abdom Radiol (NY)       Date:  2021-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.